| Dr Genevieve Chartrand, MD | |
|
2000 Medical Pkwy Ste 600, Annapolis, MD 21401-3748 | |
| (410) 991-0080 | |
| Not Available |
| Full Name | Dr Genevieve Chartrand |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 2000 Medical Pkwy Ste 600, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336846120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | R23199 (ZZ) | Primary |
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
Houses today are so well sealed that they can trap humidity and pollutants indoors as a result of insufficient ventilation. Recently, a team of Canadian scientists led by Dr. Tom Kovesi, a pediatric respirologist at the Children's Hospital of Eastern Ontario in Ottawa, Canada, performed a randomized double-blind, placebo controlled trial to determine whether use of heat recovery ventilators would increase home ventilation and therefore reduce the risk of lower respiratory tract illness in young children.
The walls have been painted, the new floor tiles have been set and new science equipment has been installed in time for the dedication of the University of Florida Southwest Florida Research and Education Center's 7,000-square-foot expansion. The dedication ceremony is set for Tuesday, Jan. 5, at 10 a.m.
An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.
ARCA biopharma, Inc. today announced that it has submitted a study protocol for review under the U.S. Food and Drug Administration's (FDA) Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of GencaroTM, in approximately 3,000 patients with chronic heart failure who have the genotype that appears to respond most favorably to Gencaro. Gencaro is the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator.
A University of Alberta-led research team has taken a major step forward in understanding how T cells are activated in the course of an immune response by combining nanotechnology and cell biology. T cells are the all important trigger that starts the human body's response to infection.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Genevieve Chartrand, MD 2445 Holly Ave Apt 612, Annapolis, MD 21401-4155 Ph: (410) 991-0080 | Dr Genevieve Chartrand, MD 2000 Medical Pkwy Ste 600, Annapolis, MD 21401-3748 Ph: (410) 991-0080 |
News Archive
Houses today are so well sealed that they can trap humidity and pollutants indoors as a result of insufficient ventilation. Recently, a team of Canadian scientists led by Dr. Tom Kovesi, a pediatric respirologist at the Children's Hospital of Eastern Ontario in Ottawa, Canada, performed a randomized double-blind, placebo controlled trial to determine whether use of heat recovery ventilators would increase home ventilation and therefore reduce the risk of lower respiratory tract illness in young children.
The walls have been painted, the new floor tiles have been set and new science equipment has been installed in time for the dedication of the University of Florida Southwest Florida Research and Education Center's 7,000-square-foot expansion. The dedication ceremony is set for Tuesday, Jan. 5, at 10 a.m.
An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma pointing to a potential new target for treatment against the illness.
ARCA biopharma, Inc. today announced that it has submitted a study protocol for review under the U.S. Food and Drug Administration's (FDA) Special Protocol Assessment (SPA) process for the design of a clinical trial to assess the safety and efficacy of GencaroTM, in approximately 3,000 patients with chronic heart failure who have the genotype that appears to respond most favorably to Gencaro. Gencaro is the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator.
A University of Alberta-led research team has taken a major step forward in understanding how T cells are activated in the course of an immune response by combining nanotechnology and cell biology. T cells are the all important trigger that starts the human body's response to infection.
› Verified 9 days ago
Dr. Robert Cleaveland Moore, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 600 Ridgely Ave, Suite222, Annapolis, MD 21401 Phone: 410-266-5084 Fax: 410-266-7289 | |
Dr. David E Matteson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1000 Fax: 443-481-1360 | |
Craig J Schaefer, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2001 Medical Pkwy, Acute Care Pavilion, Annapolis, MD 21401 Phone: 443-481-1000 Fax: 443-481-1360 | |
Dr. Steven L Quigley, MD Surgery Medicare: Medicare Enrolled Practice Location: 2001 Medical Parkway, Annapolis, MD 21401 Phone: 443-481-1000 Fax: 443-481-1360 | |
Dr. Wen Chi Liang, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 200, Annapolis, MD 21401 Phone: 443-481-5300 Fax: 443-481-6705 | |
Patrick P. Schimpf, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 410-604-0005 | |
Meghan L. Milburn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-5300 Fax: 443-481-6705 |